Drug
Torasemide PR
Torasemide PR: highest development phase Post-Market, developed by Ferrer. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Ferrer
Trials
| Drug | Phase | Indication |
|---|---|---|
| torasemide-PR NCT01549158 | Post-Market | Compensated Heart Failure |
Latest
No recent events.
Follow Torasemide PR on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.